IL114891A0 - 3-substituted-2- oxindoles as inhibitors of viral replication - Google Patents

3-substituted-2- oxindoles as inhibitors of viral replication

Info

Publication number
IL114891A0
IL114891A0 IL11489195A IL11489195A IL114891A0 IL 114891 A0 IL114891 A0 IL 114891A0 IL 11489195 A IL11489195 A IL 11489195A IL 11489195 A IL11489195 A IL 11489195A IL 114891 A0 IL114891 A0 IL 114891A0
Authority
IL
Israel
Prior art keywords
oxindoles
inhibitors
substituted
viral replication
replication
Prior art date
Application number
IL11489195A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL114891A0 publication Critical patent/IL114891A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL11489195A 1994-08-17 1995-08-10 3-substituted-2- oxindoles as inhibitors of viral replication IL114891A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29213894A 1994-08-17 1994-08-17

Publications (1)

Publication Number Publication Date
IL114891A0 true IL114891A0 (en) 1995-12-08

Family

ID=23123389

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11489195A IL114891A0 (en) 1994-08-17 1995-08-10 3-substituted-2- oxindoles as inhibitors of viral replication

Country Status (8)

Country Link
JP (1) JPH0859464A (ja)
KR (1) KR960006923A (ja)
CN (1) CN1123144A (ja)
AU (1) AU2859495A (ja)
CA (1) CA2156120A1 (ja)
HU (1) HUT73810A (ja)
IL (1) IL114891A0 (ja)
ZA (1) ZA956831B (ja)

Also Published As

Publication number Publication date
CA2156120A1 (en) 1996-02-18
JPH0859464A (ja) 1996-03-05
HUT73810A (en) 1996-09-30
CN1123144A (zh) 1996-05-29
AU2859495A (en) 1996-02-29
KR960006923A (ko) 1996-03-22
ZA956831B (en) 1997-02-17
HU9502420D0 (en) 1995-10-30

Similar Documents

Publication Publication Date Title
PL311736A1 (en) Derivatives of 1h-imidazoles
PL322549A1 (en) Inhibitors of proteinous farnesiltransferase
PL322584A1 (en) Inhibitors of proteinous kinase c
PL326754A1 (en) Inhibitors of proteinous kinase c
DE69533256D1 (en) Chimäre komplement inhibitor proteine
PL327569A1 (en) Promedications of thrombosin inhibitors
PL340727A1 (en) Benzothiazolic inhibitors of proteinous thyrosinic kinase
PL333918A1 (en) Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors
PL319485A1 (en) Purinic and guanic compounds as pnp inhibitors
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
IL113850A0 (en) Process and intermediates for the preparation of 3-aryluracils
AU6774294A (en) Methods of preventing viral replication
AU3107795A (en) Inhibitors of the benzamidine type
PL319905A1 (en) Apolipoprotein b synthesis inhibitors
AU3586395A (en) Methods and compositions for inhibiting production of replication competent virus
GB9425701D0 (en) Enzyme inhibitors
ZA957113B (en) Use of N-substituted pyhenothiazines
PL312692A1 (en) New derivatives of dialkoxy-pyridinol-benzimidazole
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
AU4248297A (en) Inhibition of viral replication
HU9700071D0 (en) Use of muramilpeptides
HU9503783D0 (en) Squvalen syntetase inhibitors
GB9515802D0 (en) Hiv protease inhibitors useful for the treatment of aids
AU6378598A (en) Method for inhibition of virus replication
EP0833668A4 (en) INHIBITATION OF THE HEPATITIS B VIRUS REPLICATION